Founder and Chief Innovation Officer
As Founder and Chief Innovation officer at Psivant Therapeutics, Woody Sherman, Ph.D. provides vision for Psivant’s mission to design better therapeutics, atom by atom. Woody brings over 20 years of industry experience and has published more than 100 peer reviewed scientific publications that span a broad range of topics, including molecular dynamics, quantum mechanics, free energy simulations, protein design, machine learning, cheminformatics and computer-aided drug design. Woody is the original architect of the QUAISAR platform; he led the platform team from its inception and continues to provide strategic guidance in developing novel methods that overcome critical challenges in Psivant’s drug discovery projects.
Prior to founding and serving as Chief Executive Officer at Psivant from 2022–24, Woody was Chief Computational Scientist at Roivant Sciences from 2021–22. From 2017–21, Woody served as Chief Scientific Officer at Silicon Therapeutics and from 2009–17 he was Vice President and Global Head of Applications science at Schrödinger, Inc.
Woody earned his Ph.D. in physical chemistry at Massachusetts Institute of Technology (MIT) in Cambridge, Massachusetts. His bachelor of science degree in chemistry and bachelor of arts in creative studies are from the University of California at Santa Barbara.